Brookings Workshop Explores Cultural Changes Needed To Drive mHealth
This article was originally published in The Gray Sheet
Physicians and patients may need to become more comfortable with giving up some privacy in exchange for achieving better clinical outcomes, speakers suggested at a Brookings Institution workshop.
You may also be interested in...
The Senate user fee reauthorization and FDA reform bill, formally introduced May 15, includes several new provisions, including a moratorium on FDA issuing final guidance on mobile medical apps. The bill should see action on the Senate floor this week.
The European Safety Authority is running consultations on its proposals to set safe intake levels from foods, including dietary supplements, for iron and vitamin A.
Pipeline is concentrated around Phase II, but sponsors have a few chances to see how FDA handles its ‘foundational constructs’ for psychedelic drugs, led by Lykos’ pending NDA for PTSD and Compass Pathways’ Phase III synthetic psilocybin COMP360 for treatment-resistant depression.